1. Home
  2. PHUN vs BCTX Comparison

PHUN vs BCTX Comparison

Compare PHUN & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Phunware Inc.

PHUN

Phunware Inc.

SELL

Current Price

$2.05

Market Cap

42.6M

Sector

Technology

ML Signal

SELL

BCTX

BriaCell Therapeutics Corp.

SELL

Current Price

$3.64

Market Cap

36.6M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
PHUN
BCTX
Founded
2009
2014
Country
United States
Canada
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
42.6M
36.6M
IPO Year
2016
2025

Fundamental Metrics

Financial Performance
Metric
PHUN
BCTX
Price
$2.05
$3.64
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
77.4K
★ 125.6K
Earning Date
11-05-2026
10-27-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 39.36
N/A
EPS
★ N/A
N/A
Revenue
★ $30,883,000.00
N/A
Revenue This Year
$37.21
N/A
Revenue Next Year
$1,931.97
$380.95
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 15.57
N/A
52 Week Low
$1.56
$2.60
52 Week High
$2.87
$14.68

Technical Indicators

Market Signals
Indicator
PHUN
BCTX
Relative Strength Index (RSI) 49.39 39.16
Support Level $1.96 $3.35
Resistance Level $2.11 $3.74
Average True Range (ATR) 0.06 0.22
MACD 0.00 -0.07
Stochastic Oscillator 44.29 4.93

Price Performance

Historical Comparison
PHUN
BCTX

About PHUN Phunware Inc.

Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States. The company has two reportable segments: Software subscriptions and services; and Advertising. It derives maximum revenue from Software subscriptions and services. Development services for customers who wish to have a customized application experience; and In-app advertising services for mobile audience building, user acquisition, application discovery, audience engagement and monetization.

About BCTX BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

Share on Social Networks: